This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.15% per year. These returns cover a period from January 1, 1988 through June 3, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Reasons Why Investors Should Retain Sun Life (SLF) Stock Now
by Zacks Equity Research
Sun Life (SLF) stands to benefit from strategic investments in Asia, strengthening asset management businesses, the scale-up of its U.S. operations and a strong financial position.
Why You Should Stay Invested in Arch Capital (ACGL) Stock
by Zacks Equity Research
Arch Capital (ACGL) remains poised to gain from new business opportunities, rate improvement, favorable estimates and a solid capital position.
Aflac (AFL), SKYGEN Team Up to Enhance Dental and Vision Services
by Zacks Equity Research
Aflac (AFL) joins forces with SKYGEN to improve dental and vision benefit management, boosting customer satisfaction and AFL's product sales through advanced technology and streamlined processes.
Arthur J. Gallagher (AJG) Buys Cleary Benefits, Spurs Portfolio
by Zacks Equity Research
Arthur J. Gallagher's (AJG) buyout of Cleary Benefits is set to enhance its benefits consulting capabilities and expand its operations in the northeast region.
Reasons Why Investors Should Consider Buying RLI Stock Now
by Zacks Equity Research
RLI stands to gain from a compelling product portfolio, rise in rate, improved retention, higher premium receipts, sufficient liquidity and effective capital deployment.
NMIH or CB: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
NMIH vs. CB: Which Stock Is the Better Value Option?
Should You Retain Trupanion (TRUP) Stock in Your Portfolio?
by Zacks Equity Research
Trupanion (TRUP) gains from a focus on pet health and well-being in the pet insurance market. Its solid balance sheet supports investment in new product development and international expansion.
EverQuote (EVER) Rallies 220% in a Year: What's Driving It?
by Zacks Equity Research
EverQuote (EVER) rallies on the back of higher consumer traffic, solid performance of automotive and other insurance marketplace verticals, favorable growth estimates and solid capital position.
Why You Should Hold American International (AIG) Stock Now
by Zacks Equity Research
American International (AIG) is expected to benefit from rising premiums in the General Insurance business, improving investment income, enhanced savings from AIG Next, and streamlining initiatives.
Here's Why You Should Hold Brighthouse Financial (BHF) Now
by Zacks Equity Research
Brighthouse Financial (BHF) gains from higher annuity and life insurance sales, conservative investment strategy, improved interest rates and effective capital deployment.
Here's Why Hold Strategy is Apt for CNA Financial (CNA) Stock
by Zacks Equity Research
CNA Financial (CNA) remains poised to grow on the back of strong rate, higher income from limited partnership, improved net earned premium and sufficient liquidity.
Allstate (ALL) Rises 45% in a Year: Evaluating the Road Ahead
by Zacks Equity Research
Allstate (ALL) remains well-poised for growth on higher P&C insurance premiums, strategic acquisitions and cost-cutting initiatives.
Should You Add NMI Holdings (NMIH) Stock for Better Returns?
by Zacks Equity Research
NMI Holdings (NMIH) is set to grow on an improving mortgage insurance portfolio, higher new insurance written volume, a comprehensive reinsurance program and a solid capital position.
Here's Why NMI Holdings (NMIH) is a Strong Momentum Stock
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Should You Retain Progressive (PGR) Stock in Your Portfolio?
by Zacks Equity Research
Progressive (PGR) is poised to grow from its compelling portfolio, leadership position, strength in Vehicle and Property businesses, healthy policies in force, retention and a solid capital position.
MetLife (MET), GeoBlue Unveil Globaline for Expatriate Benefits
by Zacks Equity Research
MetLife (MET) and GeoBlue launch Globaline, a comprehensive expatriate benefits solution, offering unified medical and ancillary coverage, leveraging extensive global health networks for seamless support.
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Discover Financial (DFS) Expands Reach in Singapore With NETS
by Zacks Equity Research
Discover Financial (DFS) accelerates its footprint in Singapore with NETS and enhances cardholder experience.
Marsh & McLennan (MMC) Unit Buys Commodity Trading Firm
by Zacks Equity Research
Marsh & McLennan's (MMC) sub-unit, Oliver Wyman, is set to acquire Veritas Total Solutions, enhancing its commodity trading advisory services.
NMIH vs. CB: Which Stock Is the Better Value Option?
by Zacks Equity Research
NMIH vs. CB: Which Stock Is the Better Value Option?
Here's Why You Should Hold Selective Insurance (SIGI) Stock
by Zacks Equity Research
Selective Insurance (SIGI) stands to benefit from strong renewal, fuel price increases, exposure growth, higher income earned on fixed-income securities portfolio and prudent capital deployment.
4 Insurers That Have Outperformed the S&P 500 in a Year
by Sushmita Sarker
Insurers like HCI Group (HCI), NMI Holdings (NMIH), Reinsurance Group of America (RGA) and Old Republic International (ORI) outperform the industry, the sector and the S&P 500 composite and look poised to retain the rally.
Here's Why You Should Add Palomar Holdings (PLMR) to Your Kitty
by Zacks Equity Research
Palomar Holdings (PLMR) is poised to gain from the expansion of its products' geographic and distribution footprint, new partnerships, higher average balance of investments and improved loss ratio.
Reasons Why You Should Add RLI Stock to Your Portfolio Now
by Zacks Equity Research
RLI stands to gain from a compelling product portfolio, rate increases, improved retention, higher premium receipts, sufficient liquidity and effective capital deployment.